People who have had COVID-19, even mild cases, tend to have cardiovascular imbalances in the short and medium term and need to undergo rehabilitation. This was the finding of a study of 130 volunteers ...

Among patients with mild to moderate COVID-19, the asthma drug montelukast (Singulair) did not reduce duration of symptoms, results of the randomized controlled ACTIV-6 trial showed. After receiving ...

Unvaccinated volunteers who contracted COVID-19 in a human challenge study showed significant memory and executive function decline lasting up to a year, despite no reported subjective symptoms, ...

22% more likely to have a pulmonary issue. Dr. Ishwara Sankara, a neurointensivist with Texas Health Fort Worth, told KERA’s Sam Baker this may stem from inflammation. COVID-19 showed us the ...

Brazilian researchers reveal that even mild cases of COVID-19 can temporarily reduce heart rate variability, with stress on the autonomic nervous system lasting up to six months—especially in older ...

Ducharme is a contributor to TIME. A cot and pillowcase on the National Mall during a demonstration by Long COVID and ME/CFS patients in Washington, D.C., on May 12, 2023. Ducharme is a contributor to ...

For many people, a case of COVID-19 lasts a week or two. For millions of adults, though, symptoms stick around for weeks, months, even years. Long COVID is associated with more than 200 symptoms that ...